Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing
暂无分享,去创建一个
I. Peene | L. Meheus | F. de Keyser | F De Keyser | E M Veys | I Peene | E. Veys | F. Keyser | L Meheus
[1] J. McCluskey,et al. Transfection and overexpression of the human 60-kDa Ro/SS-A autoantigen in HEp-2 cells. , 1994, Clinical immunology and immunopathology.
[2] A Kavanaugh,et al. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. , 2000, Archives of pathology & laboratory medicine.
[3] J. Koziol,et al. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. , 1999, Arthritis and rheumatism.
[4] M. Fritzler,et al. Detection of autoantibodies to ss‐a/ro by indirect immunofluorescence using a transfected and overexpressed human 60 kd ro autoantigen in hep‐2 cells , 1995, Journal of clinical laboratory analysis.
[5] W Emlen,et al. Clinical significance of antinuclear antibodies: comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays. , 1997, Arthritis and rheumatism.
[6] Rothfield Nf,et al. Clinical significance of antinuclear antibodies. , 1967 .
[7] E. Tan,et al. Autoantibodies in the diagnosis of systemic rheumatic diseases. , 1995, Seminars in arthritis and rheumatism.
[8] D. Isenberg,et al. The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies. , 1999, Journal of autoimmunity.
[9] D Gianola,et al. Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders. , 1999, Clinical and experimental rheumatology.
[10] D. Keren. Antinuclear antibody testing. , 2002, Clinics in laboratory medicine.
[11] J. Koziol,et al. Range of antinuclear antibodies in "healthy" individuals. , 1997, Arthritis and rheumatism.
[12] I. Peene,et al. Sensitivity of the HEp-2000 Substrate for the Detection of Anti-SSA/Ro60 Antibodies , 2000, Clinical Rheumatology.
[13] H. Homburger. Cascade testing for autoantibodies in connective tissue diseases. , 1995, Mayo Clinic proceedings.
[14] N. Rothfield,et al. Clinical significance of antinuclear antibodies. , 1967, Journal of the Medical Association of Georgia.
[15] R. Maini,et al. Manual of Biological Markers of Disease , 1996, Springer Netherlands.
[16] E. Tan,et al. Autoantibodies in the diagnosis of systemicrheumatic diseases , 1995 .
[17] R. Humbel,et al. Detection of antinuclear antibodies by immunofluorescence , 1996 .
[18] R. Winchester,et al. Effective separation of the 52 kDa SSA/Ro polypeptide from the 48 kDa SSB/La polypeptide by altering conditions of polyacrylamide gel electrophoresis. , 1990, Journal of immunological methods.
[19] N. Pourmand,et al. The Zn2+ binding domain of the human Ro 52 kDa protein is a target for conformation-dependent autoantibodies. , 1998, Journal of autoimmunity.
[20] R. Shmerling,et al. Antinuclear antibody testing. A study of clinical utility. , 1996, Archives of internal medicine.